FDA approves Mylan's biosimilar of Roche's cancer drug Herceptin

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar version of Roche's blockbuster breast cancer treatment Herceptin.

from Reuters: Health News http://ift.tt/2Aw1Nr3